MultiPlan Corporation (MPLN)

1 member of Congress has disclosed 1 trade in MultiPlan Corporation (MPLN) via STOCK Act filings. The most recent disclosure was a sale by Susie Lee on 12 November 2020. Aggregate disclosed activity totals roughly $8K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for MPLN
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for MPLN

1 transactions
Compliance: 100%
Susie Lee12 Nov 20208 Dec 2020SaleStock$1,001 - $15,000N/A

Stock Overview

Market Data

Market Cap

$374.98M

Volume

204.84K

Beta

0.33

P/E Ratio

-0.23

Fundamentals

EPS

$-101.92

Div. Yield

-

Open

$23.99

Day Range

$22.77 – $24.99

Company Information

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
NYSE · USD
Country
US
CEO
Melissa Humphrey
IPO Date
2020-04-03

MultiPlan Corporation, through its various subsidiaries, supplies advanced data analytics and technology-driven solutions to the United States healthcare sector. These services are primarily aimed at optimizing cost management, streamlining payment p...

Earnings

Recent Quarters

Q4 202526 Feb
EPS$-4.88
Q3 20253 Nov
EPS$-4.23
Q2 202530 Jul
EPS$-3.81
Q1 20256 May
EPS$-4.38
Miss 104.8%
Q4 202425 Feb
EPS$-8.50
Beat 13.4%
Q3 20245 Nov
EPS$-24.25
Miss 923.2%
Q2 20241 Aug
EPS$-35.60
Miss 2125.0%
Q1 20248 May
EPS$-33.20
Miss 1453.7%
Q4 202329 Feb
EPS$-1.60
Beat 26.6%
Q3 20237 Nov
EPS$-1.60
Beat 30.6%
Q2 20232 Aug
EPS$-2.40
Miss 14.0%
Q1 20234 May
EPS$-2.40
Miss 3900.0%
Q4 202228 Feb
EPS$-8.00
Miss 335.4%
Q3 20228 Nov
EPS$1.20
Beat 0.8%
Q2 20224 Aug
EPS$0.80
Beat 1970.4%
Q1 202210 May
EPS$2.80
Beat 7895.4%
Q4 202117 Feb
EPS$1.60
Beat 3159.3%
Q3 20213 Nov
EPS$4.80
Beat 11900.0%
Q2 20215 Aug
EPS$1.20
Beat 50.0%
Q1 202113 May
EPS$0.80
Beat 7900.0%
Q4 202016 Mar
EPS$-10.80
Miss 11900.0%
Q3 202013 Nov
EPS$-11.20
Miss 27900.0%
Q2 202012 Aug
EPS$-5.60
Q1 202012 May
EPS$-0.83
Q4 201914 Feb
EPS$3.80
Q1 201930 Jun
EPS$-1.20
Q4 201831 Mar
EPS$-1.20

1 politician traded within 30 days

No dividend data available for this stock.

Stock Splits

Split History

23 Sept 2024Reverse Split
Ratio1:40
13 Jul 2015Stock Split
Ratio8:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about MPLN

Which members of Congress have traded MPLN?
1 member of Congress has disclosed 1 trade in MultiPlan Corporation (MPLN) under the STOCK Act: Susie Lee.
When was MPLN most recently disclosed by Congress?
The most recent MPLN disclosure was a sale by Susie Lee on 12 November 2020.
What is the total disclosed congressional trading volume for MPLN?
Members of Congress have disclosed approximately $8K in MPLN sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in MPLN?
This MPLN page updates as soon as new STOCK Act disclosures are filed for MultiPlan Corporation. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.